Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Director Timothy A. Springer Acquires 5,514 Shares
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) Director Timothy A. Springer purchased 5,514 shares of the business’s stock in a transaction on Wednesday, October 2nd. The shares were acquired at an average price of $17.38 per share, for a total transaction of $95,833.32. Following the completion of the purchase, the director now directly owns […]
More Stories
How to Build a Cleaning Routine That Helps Reduce Household Dust
Why a Cleaning Routine Matters Household dust has a way of settling everywhere—on floors, countertops, bedding, shelves, and the tops...
The Midterm Fraud Machine: How Corruption, Confusion, and Judicial Abdication Are Stealing America’s 2026 Elections
By Stephen Zogopoulos, USNN World News On November 3, 2026, Americans went to the polls in a midterm election that...
US Economy in Late 2026: Steady Growth, Sticky Inflation, and a Return to Tariff-Based Trade Policy
By Stephen Zogopoulos, USNN World News As of early November 2026, the U.S. economy continues to expand at a moderate...
Major Automakers Side With Trump in Legal Battle Over Eased Fuel Economy Standards
By Kimberly Hayek A major auto industry group has thrown its support behind the Trump administration in a lawsuit brought...
Oil Prices Rise After Reports of Explosions on Iran’s Qeshm Island
By Evgenia Filimianova Oil prices climbed by more than 1.5 percent early on Nov. 3 after reports of explosions on...
Spanish Police Launch Investigation Into Death of Soccer Player After On-field Incident
By Elma Aksalic Spanish authorities have launched an investigation following the death of professional soccer player Jesús de Miguel, who...